Page 39 - JCBP-2-1
P. 39

Journal of Clinical and
            Basic Psychosomatics                                                        The endocannabinoid system



            58.  Shipston MJ, 2022, Glucocorticoid action in the anterior   the endocannabinoid system in the regulation of intestinal
               pituitary gland: Insights from corticotroph physiology. Curr   homeostasis. Cell Mol Gastroenterol Hepatol, 14: 947–963.
               Opin Endocr Metab Res, 25: 100358.
                                                                  https://doi.org/10.1016/j.jcmgh.2022.05.015
               https://doi.org/10.1016/j.coemr.2022.100358
                                                               71.  Osafo N, Yeboah OK, Antwi AO, 2021, Endocannabinoid
            59.  Wang M, Yang Y, Xu Y, 2023, Brain nuclear receptors and   system and  its modulation of brain, gut,  joint and skin
               cardiovascular function. Cell Biosci, 13: 14.      inflammation. Mol Biol Rep, 48: 3665–3680.
               https://doi.org/10.1186/s13578-023-00962-3         https://doi.org/10.1007/s11033-021-06366-1
            60.  Iob E, Steptoe A, 2019, Cardiovascular disease and hair   72.  Agirman G, Yu KB, Hsiao EY, 2021, Signaling inflammation
               cortisol: A novel biomarker of chronic stress. Curr Cardiol   across the gut-brain axis. Science, 374: 1087–1092.
               Rep, 21: 116.
                                                                  https://doi.org/10.1126/science.abi6087
               https://doi.org/10.1007/s11886-019-1208-7
                                                               73.  Morreale C, Bresesti I, Bosi A, et al., 2022, Microbiota and
            61.  Khan MS, Aouad R, 2022, The effects of insomnia and sleep   pain: Save your gut feeling. Cells, 11: 971.
               loss on cardiovascular disease. Sleep Med Clin, 17: 193–203.
                                                                  https://doi.org/10.3390/cells11060971
               https://doi.org/10.1016/j.jsmc.2022.02.008
                                                               74.  Sabo  CM,  Dumitrascu  DL,  2021,  Microbiota  and  the
            62.  Liu B, Zhang TN, Knight JK, et al., 2019, The glucocorticoid   irritable bowel syndrome. Minerva Gastroenterol (Torino),
               receptor in cardiovascular health and disease. Cells, 8: 1227.   67: 377–384.
               https://doi.org/10.3390/cells8101227               https://doi.org/10.23736/s2724-5985.21.02923-5
            63.  Azizi M, 2020, Aldosterone receptor antagonists.  Ann   75.  Yan M, Man S, Sun B, et al., 2023, Gut liver brain axis in
               Endocrinol (Paris), 82: 179–181.                   diseases: The implications for therapeutic interventions.
                                                                  Signal Transduct Target Ther, 8: 443.
               https://doi.org/10.1016/j.ando.2020.03.009
                                                                  https://doi.org/10.1038/s41392-023-01673-4
            64.  Motavalli R, Majidi T, Pourlak T, et al., 2021, The clinical
               significance of the glucocorticoid receptors: Genetics and   76.  Peppas S, Pansieri C, Piovani D, et al., 2021, The brain-gut
               epigenetics. J Steroid Biochem Mol Biol, 213: 105952.   axis: Psychological functioning and inflammatory bowel
                                                                  diseases. J Clin Med, 10: 377.
               https://doi.org/10.1016/j.jsbmb.2021.105952
                                                                   https://doi.org/10.3390/jcm10030377
            65.  De Kloet ER, 2023, Glucocorticoid feedback paradox:
               A homage to Mary Dallman. Stress, 26: 2247090.   77.  Ding M, Lang Y, Shu H, et al., 2021, Microbiota-gut-brain
                                                                  axis and epilepsy: A review on mechanisms and potential
               https://doi.org/10.1080/10253890.2023.2247090
                                                                  therapeutics. Front Immunol, 12: 742449.
            66.  Talarowska M, 2020, Epigenetic mechanisms in the
               neurodevelopmental theory of depression.  Depress Res      https://doi.org/10.3389/fimmu.2021.742449
               Treat, 2020: 6357873.                           78.  Xu Q, Jiang M, Gu S, et al., 2022, Metabolomics changes
                                                                  in brain-gut axis after unpredictable chronic mild stress.
               https://doi.org/10.1155/2020/6357873
                                                                  Psychopharmacology (Berl), 239: 729–743.
            67.  Dempster KS, O’Leary DD, MacNeil AJ, et al., 2021, Linking
               the hemodynamic consequences of adverse childhood      https://doi.org/10.1007/s00213-021-05958-w
               experiences to an altered HPA axis and acute stress response.   79.  Simpson S, Mclellan R, Wellmeyer E,  et al., 2022, Drugs
               Brain Behav Immun, 93: 254–263.                    and bugs: The gut-brain axis and substance use disorders.
                                                                  J Neuroimmune Pharmacol, 17: 33–61.
               https://doi.org/10.1016/j.bbi.2020.12.018
                                                                  https://doi.org/10.1007/s11481-021-10022-7
            68.  Goldberger JJ, Arora R, Buckley U, et al., 2019, Autonomic
               nervous system dysfunction: JACC focus seminar. J Am Coll   80.  Timmers I, Quaedflieg CWE, Hsu C,  et  al., 2019, The
               Cardiol, 73: 1189–1206.                            interaction between stress and chronic pain through the lens
                                                                  of threat learning. Neurosci Biobehav Rev, 107: 641–655.
               https://doi.org/10.1016/j.jacc.2018.12.064
                                                                  https://doi.org/10.1016/j.neubiorev.2019.10.007
            69.  Wiley JW, Higgins GA, Athey BD, 2016, Stress and
               glucocorticoid receptor transcriptional programming   81.  Fitzcharles MA, Cohen SP, Clauw DJ,  et al., 2021,
               in  time  and space:  Implications  for  the  brain-gut  axis.   Nociplastic pain: Towards an understanding of prevalent
               Neurogastroenterol Motil, 28: 12–25.               pain conditions. Lancet, 397: 2098–2110.
               https://doi.org/10.1111/nmo.12706                  https://doi.org/10.1016/S0140-6736(21)00392-5
            70.  Cuddihey H, MacNaughton WK, Sharkey KA, 2022, Role of   82.  Buisseret B, Alhouayek, M., Guillemot-Legris O, et al., 2019,


            Volume 2 Issue 1 (2024)                         15                       https://doi.org/10.36922/jcbp.2288
   34   35   36   37   38   39   40   41   42   43   44